TNF and metabolic dysfunction-associated steatotic liver disease: Patients with lean MASLD have endotoxemia, and LPS stimulates macrophages to release inflammatory factors such as tumor necrosis factor α (TNF-α) and interferon-γ by binding with Toll-like receptors (TLR), thus damaging the metabolic adaptability of the human body (Alharthi et al., 2023).